Company Analysis
Sign in

Moderna, Inc. (MRNA)

Nasdaq: MRNA · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2016
Full chart Alerts Compare
Grade5.7
◀ Past 7.3● Present 6.0▶ Future 3.6
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 20, 2026Feb 21, 2025Feb 23, 2024Feb 24, 2023Feb 25, 2022Feb 26, 2021Feb 27, 2020Mar 13, 2019··
Revenue1,944,0003,236,0006,848,00019,263,00018,471,000803,000r60,209135,068205,825108,396
Cost of revenue868,0001,464,0004,693,0005,416,0002,617,0008,000r00··
Research and development3,132,0004,543,0004,845,0003,295,0001,991,0001,370,000r496,000r454,082410,459274,717
General and administrative1,018,0001,174,0001,549,0001,132,000567,000188,000r110,000r94,25264,72257,450
Total operating expenses······605,929548,334475,181332,167
Total costs and expenses5,018,0007,181,00011,087,0009,843,0005,175,0001,566,000r606,000r548,334··
Operating income-3,074,000-3,945,000-4,239,0009,420,00013,296,000-763,000r-546,000r-413,266-269,356-223,771
Interest and investment income314,000425,000421,000200,00018,00025,000r39,000r27,02315,23511,312
Other income (expense), net-8,000-87,000-124,000-45,000-29,000-6,000r-8,000r1,835-1,875-2,709
Income before income taxes-2,768,000-3,607,000-3,942,0009,575,00013,285,000-744,000-515,000-384,408-255,996-215,168
Income tax expense54,000-46,000772,0001,213,0001,083,0003,000r-1,000r326-801,043
Net income-2,822,000-3,561,000-4,714,0008,362,00012,202,000-747,000r-514,000r-384,734-255,916-216,211
Net income to common shareholders·····-747,064-514,021-401,857-269,841-230,314
Earnings per share, basic-7.26-9.28-12.3321.2630.31-1.96-1.55···
Earnings per share, diluted-7.26-9.28-12.3320.1228.29-1.96-1.55···
Earnings per share, basic and diluted·····-1.96-1.55-4.95-4.18-3.79
Weighted average shares, basic389,000,000384,000,000382,000,000394,000,000403,000,000381,000,000331,000,000···
Weighted average shares, diluted389,000,000384,000,000382,000,000416,000,000431,000,000381,000,000331,000,000···
Weighted average shares, basic and diluted·····381,333,059330,802,13681,114,18364,497,54460,747,426
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton MRNA · research, not advice